{"transactions":[{"id":4623121,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-21T19:20:53.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":18.14,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001193125-26-396584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526396584/ownership.xml","form_type":"4"}},{"id":4623120,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-21T19:20:53.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option vested on January 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":14.39,"expiration_date":"2032-01-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-396584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526396584/ownership.xml","form_type":"4"}},{"id":4623119,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-21T19:20:53.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":52500,"price":37.8935,"value":1989408.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales\nprices for the transactions ranged from $37.62 to $38.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":15167,"source":{"system":"sec-edgar","filing":"0001193125-26-396584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526396584/ownership.xml","form_type":"4"}},{"id":4623118,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-21T19:20:53.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":17500,"price":18.14,"value":317450.0,"ownership":{"direct":true},"balance_after":67667,"source":{"system":"sec-edgar","filing":"0001193125-26-396584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526396584/ownership.xml","form_type":"4"}},{"id":4623117,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-21T19:20:53.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":14.39,"value":503650.0,"ownership":{"direct":true},"balance_after":50167,"source":{"system":"sec-edgar","filing":"0001193125-26-396584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526396584/ownership.xml","form_type":"4"}},{"id":766911,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-22T18:54:12.000Z","date":"2026-05-20","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise and sale from 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter."}],"balance_after":11000,"derivative":{"exercise_price":8.05,"expiration_date":"2033-04-06","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001193125-26-236432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526236432/ownership.xml","form_type":"4"}},{"id":766910,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T18:54:12.000Z","date":"2026-05-20","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":29.3166,"value":293166.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise and sale from 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $29.03 to $29.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":15167,"source":{"system":"sec-edgar","filing":"0001193125-26-236432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526236432/ownership.xml","form_type":"4"}},{"id":766909,"issuer":{"id":4374,"kind":"organization","name":"Pharvaris N.V.","symbol":"PHVS"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T18:54:12.000Z","date":"2026-05-20","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":8.05,"value":80500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a scheduled exercise and sale from 10b5-1 trading plan."}],"balance_after":25167,"source":{"system":"sec-edgar","filing":"0001193125-26-236432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830487/000119312526236432/ownership.xml","form_type":"4"}},{"id":946955,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-06T21:05:11.000Z","date":"2026-01-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.44,"value":34400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes 30,000 restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001140361-26-000378","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036126000378/form4.xml","form_type":"4"}},{"id":1054613,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-28T00:54:13.000Z","date":"2025-08-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.41,"value":34100.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes 30,000 restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001140361-25-033017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036125033017/form4.xml","form_type":"4"}},{"id":1084745,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T20:05:35.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":". Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":". Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001140361-25-026405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036125026405/form4.xml","form_type":"4"}},{"id":1380065,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-29T21:05:38.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 607 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on September 26, 2025."}],"balance_after":607,"derivative":{"exercise_price":17.6,"expiration_date":"2034-09-26","underlying":"Common Stock","underlying_shares":607},"source":{"system":"sec-edgar","filing":"0001140361-24-044548","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036124044548/form4.xml","form_type":"4"}},{"id":1473311,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:10:28.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":3325,"price":15.04,"value":50008.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 3,325 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000."}],"balance_after":3325,"derivative":{"exercise_price":22.86,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":3325},"source":{"system":"sec-edgar","filing":"0001140361-24-030731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036124030731/form4.xml","form_type":"4"}},{"id":1473310,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:10:28.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":23944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025."}],"balance_after":23944,"derivative":{"exercise_price":22.86,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":23944},"source":{"system":"sec-edgar","filing":"0001140361-24-030731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036124030731/form4.xml","form_type":"4"}},{"id":1844301,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T23:47:49.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":3590,"price":13.93,"value":50008.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 3,590 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000."}],"balance_after":3590,"derivative":{"exercise_price":21.56,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":3590},"source":{"system":"sec-edgar","filing":"0001140361-23-031526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036123031526/form4.xml","form_type":"4"}},{"id":1844300,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T23:47:49.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":25850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024."}],"balance_after":25850,"derivative":{"exercise_price":21.56,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":25850},"source":{"system":"sec-edgar","filing":"0001140361-23-031526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036123031526/form4.xml","form_type":"4"}},{"id":2231563,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T01:07:28.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":7345,"price":6.8,"value":49946.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 7,345 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000."}],"balance_after":7345,"derivative":{"exercise_price":10.77,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":7345},"source":{"system":"sec-edgar","filing":"0001140361-22-023149","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036122023149/form4.xml","form_type":"4"}},{"id":2231562,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T01:07:28.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":47745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023."}],"balance_after":47745,"derivative":{"exercise_price":10.77,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":47745},"source":{"system":"sec-edgar","filing":"0001140361-22-023149","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036122023149/form4.xml","form_type":"4"}},{"id":2666486,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T23:55:55.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":1699,"price":29.42,"value":49984.58,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 1,699 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000."}],"balance_after":1699,"derivative":{"exercise_price":47.25,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":1699},"source":{"system":"sec-edgar","filing":"0001140361-21-021291","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036121021291/form4.xml","form_type":"4"}},{"id":2666485,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T23:55:55.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":12236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022."}],"balance_after":12236,"derivative":{"exercise_price":47.25,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":12236},"source":{"system":"sec-edgar","filing":"0001140361-21-021291","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036121021291/form4.xml","form_type":"4"}},{"id":3105689,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T01:38:40.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021"}],"balance_after":20000,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-20-014238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036120014238/form4.xml","form_type":"4"}},{"id":3171824,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":44954,"kind":"person","name":"Bjork Elisabeth","position":1,"cik":"0001810406","reported_name":"Bjork Elisabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-22T23:14:23.000Z","date":"2020-04-20","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 1/3 of which shall vest on the first anniversary of the date of this grant and the remaining 2/3 of which shall vest in equal monthly installments over the subsequent two years."}],"balance_after":40000,"derivative":{"exercise_price":17.5,"expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-20-009478","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810406/000114036120009478/form4.xml","form_type":"4"}}]}